Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage
Eligible age
18–85 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a single-site, single-arm, open-label pilot study assessing the safety, feasibility, and efficacy of non-invasive vagus nerve stimulation (nVNS), gammaCore, for the acute treatment of aneurysmal subarachnoid hemorrhage (SAH) subjects in a neurocritical care setting. 25 patients will be enrolled, all treated with an active device. The primary efficacy outcomes are reduced aneurysm rupture rate, reduced seizure and seizure-spectrum activity, minimized hemorrhage grades, and increased survival.
Sponsor: Massachusetts General Hospital
You may qualify if…
- ✓ Male or female, 18-85 years of age
- ✓ Ruptured aneurysmal SAH confirmed by angiography and repaired by neurosurgical clipping or endovascular occlusion (coiling)
- ✓ Modified Glasgow Coma Scale (mGCS) score ≥ 10 and Hunt Hess 1-4 within 72 hours of presumed aneurysm rupture
- ✓ Enrollment and initiation of nVNS treatment must occur within 72 hours of presumed aneurysm rupture
- ✓ Provide a legally obtained informed consent form from the participant or the legally authorized representative (LAR); telephonic consent is acceptable
- ✓ Female participants of reproductive age must have a negative pregnancy test result (urine or blood)
You may not qualify if…
- ✕ Use of any concomitant electrostimulation device, including a pacemaker, defibrillator, or deep brain stimulator
- ✕ No plan to secure aneurysm, defined as aneurysm that has not been surgically or endovascularly treated
- ✕ Previous neck dissection or radiation
- ✕ History of carotid artery disease or carotid surgery/dissection
- ✕ History of secondary or tertiary heart blocks, ventricular tachycardia, or supraventricular tachycardia (SVT; including atrial fibrillation)
- ✕ Screws, metals, or devices in the neck
- ✕ Currently participating in an investigational drug or device clinical trial with potential to confound data collection
Where it's recruiting
Boston
Source: ClinicalTrials.gov · NCT05103566 · last updated 2026-05-14